Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

39.52 +0.14 (+0.37%)
Streaming Delayed Price Updated: 11:50 AM EDT, Aug 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
Expert Ratings for PROCEPT BioRobotics
 
Via Benzinga
PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue
PROCEPT BioRobotics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023 
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference
From PROCEPT BioRobotics
Via GlobeNewswire
Expert Ratings for PROCEPT BioRobotics
 
Via Benzinga
Expert Ratings for PROCEPT BioRobotics
Within the last quarter, PROCEPT BioRobotics (NASDAQ:PRCT) has observed the following analyst ratings: 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a... 
Via Benzinga
What 4 Analyst Ratings Have To Say About PROCEPT BioRobotics
Over the past 3 months, 4 analysts have published their opinion on PROCEPT BioRobotics (NASDAQ:PRCT) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
Upgrades 
Via Benzinga
PROCEPT BioRobotics to Report Third Quarter 2022 Financial Results on November 3, 2022
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics Announces $52 Million Debt Refinancing
From PROCEPT BioRobotics
Via GlobeNewswire
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
Biotech isn't the only place to make money in health care this year. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022
  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
  
Via Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
Via Benzinga
Jim Cramer Shares His Takes On Marathon Oil, T Rowe Price Group And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Marathon Oil Corp (NYSE: MRO) because he likes the oils. But he recommended not getting greedy. 
Via Benzinga
68 Biggest Movers From Yesterday
Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie... 
Via Benzinga
Procept BioRobotics' Aquablation Therapy Shows Encouraging Five-Year Data In Prostate Gland Enlargement
Procept BioRobotics Corp (NASDAQ: PRCT) announced five-year results from the WATER study comparing Aquablation therapy to TURP, the historical standard of care for... 
Via Benzinga
Earnings Scheduled For March 8, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... 
Via Benzinga
6 Underperforming IPO Stocks To Buy On The Dip
Here are six 2021 IPO stocks to buy on the dip, according to Bank of America. 
Via Talk Markets
6 Underperforming IPO Stocks To Buy On The Dip
The U.S. IPO market was red-hot in 2021. The total number of traditional U.S. IPOs hit its highest level since the dot-com boom in the late 1990s, while total IPO deal value reached record levels last... 
Via Benzinga
Where PROCEPT BioRobotics Stands With Analysts
Over the past 3 months, 6 analysts have published their opinion on PROCEPT BioRobotics (NASDAQ: 
Via Benzinga
PROCEPT BioRobotics Corporation (PRCT) Q3 2021 Earnings Call Transcript
PRCT earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021
Upgrades According to Vertical Research, the prior rating for C.H. Robinson Worldwide Inc (NASDAQ: 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by... 
Via Benzinga
56 Biggest Movers From Yesterday
Check out these big penny stock gainers and losers Losers Vera Therapeutics, Inc. (NASDAQ: VERA) shares tumbled 26.5% to settle at $22.48. MacroGenics, Inc. (NASDAQ... 
Via Benzinga
53 Biggest Movers From Yesterday
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation... 
Via Benzinga
Topics Initial Public Offering
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
IPO Previews For The Week
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these... 
Via Benzinga
Topics Initial Public Offering
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.